Cargando…
A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
BACKGROUND: The ubiquitin-editing cytosolic enzyme A20, the major negative regulator of toll-like receptor (TLR)-mediated cellular inflammatory responses, has tight genetic linkage with systemic sclerosis (SSc). Because recent studies implicate endogenous ligand-driven TLR signaling in SSc pathogene...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048449/ https://www.ncbi.nlm.nih.gov/pubmed/27716397 http://dx.doi.org/10.1186/s13075-016-1118-7 |
_version_ | 1782457592640962560 |
---|---|
author | Bhattacharyya, Swati Wang, Wenxia Graham, Lauren Van Duyn Varga, John |
author_facet | Bhattacharyya, Swati Wang, Wenxia Graham, Lauren Van Duyn Varga, John |
author_sort | Bhattacharyya, Swati |
collection | PubMed |
description | BACKGROUND: The ubiquitin-editing cytosolic enzyme A20, the major negative regulator of toll-like receptor (TLR)-mediated cellular inflammatory responses, has tight genetic linkage with systemic sclerosis (SSc). Because recent studies implicate endogenous ligand-driven TLR signaling in SSc pathogenesis, we sought to investigate the regulation, role and mechanism of action of A20 in skin fibroblasts. METHOD: A20 expression and the effects of forced A20 expression or siRNA-mediated A20 knockdown on fibrotic responses induced by transforming growth factor-ß (TGF-ß) were evaluated was evaluated in explanted human skin fibroblasts. Additionally, A20 regulation by TGF-ß, and by adiponectin, a pleiotropic adipokine with anti-fibrotic activity, was evaluated. RESULTS: In normal fibroblasts, TGF-ß induced sustained downregulation of A20, and abrogated its TLR4-dependent induction. Forced expression of A20 aborted the stimulation of collagen gene expression and myofibroblast transformation induced by TGF-ß, and disrupted canonical Smad signaling and Smad-dependent transcriptional responses. Conversely, siRNA-mediated knockdown of A20 enhanced the amplitude of fibrotic responses elicited by TGF-ß. Adiponectin, previously shown to block TLR-dependent fibrotic responses, elicited rapid and sustained increase in A20 accumulation in fibroblasts. CONCLUSION: These results identify the ubiquitin-editing enzyme A20 as a novel endogenous mechanism for negative regulation of fibrotic response intensity. Systemic sclerosis-associated genetic variants of A20 that cause impaired A20 expression or function, combined with direct suppression of A20 by TGF-ß within the fibrotic milieu, might play a significant functional role in persistence of fibrotic responses, while pharmacological augmentation of A20 inhibitory pathway activity might represent a novel therapeutic strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-1118-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5048449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50484492016-10-11 A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator Bhattacharyya, Swati Wang, Wenxia Graham, Lauren Van Duyn Varga, John Arthritis Res Ther Research Article BACKGROUND: The ubiquitin-editing cytosolic enzyme A20, the major negative regulator of toll-like receptor (TLR)-mediated cellular inflammatory responses, has tight genetic linkage with systemic sclerosis (SSc). Because recent studies implicate endogenous ligand-driven TLR signaling in SSc pathogenesis, we sought to investigate the regulation, role and mechanism of action of A20 in skin fibroblasts. METHOD: A20 expression and the effects of forced A20 expression or siRNA-mediated A20 knockdown on fibrotic responses induced by transforming growth factor-ß (TGF-ß) were evaluated was evaluated in explanted human skin fibroblasts. Additionally, A20 regulation by TGF-ß, and by adiponectin, a pleiotropic adipokine with anti-fibrotic activity, was evaluated. RESULTS: In normal fibroblasts, TGF-ß induced sustained downregulation of A20, and abrogated its TLR4-dependent induction. Forced expression of A20 aborted the stimulation of collagen gene expression and myofibroblast transformation induced by TGF-ß, and disrupted canonical Smad signaling and Smad-dependent transcriptional responses. Conversely, siRNA-mediated knockdown of A20 enhanced the amplitude of fibrotic responses elicited by TGF-ß. Adiponectin, previously shown to block TLR-dependent fibrotic responses, elicited rapid and sustained increase in A20 accumulation in fibroblasts. CONCLUSION: These results identify the ubiquitin-editing enzyme A20 as a novel endogenous mechanism for negative regulation of fibrotic response intensity. Systemic sclerosis-associated genetic variants of A20 that cause impaired A20 expression or function, combined with direct suppression of A20 by TGF-ß within the fibrotic milieu, might play a significant functional role in persistence of fibrotic responses, while pharmacological augmentation of A20 inhibitory pathway activity might represent a novel therapeutic strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-1118-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-03 2016 /pmc/articles/PMC5048449/ /pubmed/27716397 http://dx.doi.org/10.1186/s13075-016-1118-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Bhattacharyya, Swati Wang, Wenxia Graham, Lauren Van Duyn Varga, John A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
title | A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
title_full | A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
title_fullStr | A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
title_full_unstemmed | A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
title_short | A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
title_sort | a20 suppresses canonical smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048449/ https://www.ncbi.nlm.nih.gov/pubmed/27716397 http://dx.doi.org/10.1186/s13075-016-1118-7 |
work_keys_str_mv | AT bhattacharyyaswati a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator AT wangwenxia a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator AT grahamlaurenvanduyn a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator AT vargajohn a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator |